NASDAQ · YARW
Yarrow Bioscience, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for YARW: Nov 5, 2026
Yarrow Bioscience, Inc. Common Stock is estimated to report earnings on 11/05/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. The reported EPS for the same quarter last year was $-8.5.
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · Zacks · The Motley Fool · Quiver Quantitative- RTTNews · Aug 4, 4:17 AM EDTBiotech Stocks At 52-Week Highs – ANGO, ANIK, ELOX, YARW, PLSE(RTTNews) – The following biotech stocks reached a 52-week high on August 3, 2026, driven by key catalysts such as upcoming quarterly reports or the initiation of clinical trials.
- RTTNews · Jul 24, 6:22 AM EDTVYNE Finalizes Merger With Yarrow, Pays Dividend; To Trade On 1-for-50 Split Basis; Stock Plunges(RTTNews) – VYNE Therapeutics Inc. (VYNE) on Thursday announced distribution of its previously announced special cash dividend to stockholders on record July 22, 2026, in connection with its proposed merger with Yarrow Bioscience, Inc. and Yellow Merger Sub Corp.
- RTTNews · Jul 21, 9:05 AM EDTVYNE Therapeutics Approves 1-for-50 Reverse Stock Split Ahead Of Merger With Yarrow Bioscience(RTTNews) – VYNE Therapeutics Inc. (VYNE) announced that its Board of Directors has approved a 1-for-50 reverse stock split of its common stock in connection with the anticipated closing of its merger with Yarrow Bioscience, Inc.
- RTTNews · Jul 21, 8:33 AM EDTVYNE Therapeutics Sets 1-for-50 Reverse Stock Split Ahead Of Yarrow Merger(RTTNews) – VYNE Therapeutics Inc. (VYNE) said Tuesday that its board has approved a 1-for-50 reverse stock split in connection with the planned merger with Yarrow Bioscience, Inc.
- RTTNews · Jul 13, 3:59 AM EDTVYNE Therapeutics Declares Special Cash Dividend Of $0.38 Per Share Ahead Of Proposed Yarrow Merger(RTTNews) – VYNE Therapeutics Inc. (VYNE), a clinical-stage biopharmaceutical company, announced its Board of Directors has agreed to issue special cash dividend upon closure of previously announced merger with Yarrow Bioscience, Inc.
- Zacks · Nov 6, 9:15 AM ESTVYNE Therapeutics Inc. (VYNE) Reports Q3 Loss, Tops Revenue EstimatesVYNE Therapeutics (VYNE) delivered earnings and revenue surprises of +10.53% and +12.67%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Aug 14, 9:15 AM EDTVYNE Therapeutics Inc. (VYNE) Reports Q2 Loss, Lags Revenue EstimatesVYNE Therapeutics (VYNE) delivered earnings and revenue surprises of +43.48% and -31.00%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
- The Motley Fool · Aug 14, 8:21 AM EDTVYNE Reports Narrower Loss in Fiscal Q2Net loss narrowed significantly, with GAAP earnings per share of $(0.13) in Q2 2025, GAAP EPS of $(0.13) in Q2 2025 exceeded analysts' estimate of $(0.22) by $0.35.
- Zacks · Aug 12, 5:40 PM EDTMetagenomi (MGX) Reports Q2 Loss, Tops Revenue EstimatesMetagenomi (MGX) delivered earnings and revenue surprises of +20.59% and +20.50%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Aug 11, 6:55 PM EDTAquestive Therapeutics (AQST) Reports Q2 Loss, Lags Revenue EstimatesAquestive Therapeutics (AQST) delivered earnings and revenue surprises of +22.22% and -9.62%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Aug 6, 6:40 PM EDTCatalyst Pharmaceutical (CPRX) Q2 Earnings and Revenues Surpass EstimatesCatalyst (CPRX) delivered earnings and revenue surprises of +17.24% and +5.30%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
- Quiver Quantitative · Jul 2, 7:50 AM EDTVYNE Therapeutics Provides Update on VYN202 Program Following FDA Clinical Hold for Psoriasis TrialVYNE Therapeutics updates on VYN202, addressing FDA clinical hold; progress made in psoriasis treatment development.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Yarrow Bioscience, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.